Host-directed therapies for tuberculous pericarditis

International Journal of Infectious Diseases

Volumn 32, Issue , 2015, Pages 30-31

  Zumla, Alimuddin ^c   Maeurer, Markus ^b   Moll, Guido ^b   Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone marrow; Host directed; Infection; Pericarditis; Stromal cells; Treatment; Tuberculosis

Indexed keywords

PLACEBO; PREDNISOLONE; RECOMBINANT CYTOKINE; CORTICOSTEROID; GLUCOCORTICOID;

ARTICLE; BONE MARROW; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FACTORIAL DESIGN; HUMAN; MAJOR CLINICAL STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTICENTER STUDY; MYCOBACTERIUM INDICUS PRANII; PERICARDIOCENTESIS; PERICARDITIS; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOUS PERICARDITIS; IMMUNOLOGY; PERICARDITIS, TUBERCULOUS;

ADRENAL CORTEX HORMONES; GLUCOCORTICOIDS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; PERICARDITIS, TUBERCULOUS;

EID: 84925271095     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.11.017     Document Type: Article

References (26)

1. Murray C.J., Ortblad K.F., Guinovart C., et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Jul 21, pii: S0140-6736(14)60844-8.
2. Myer L., Smith E., Mayosi B.M. Medical inpatient mortality at Groote Schuur Hospital, Cape Town, South Africa, 2002-2009. S Afr Med J 2012 Nov 8, 103(1):28-31.
3. Mayosi B.M., Wiysonge C.S., Ntsekhe M., Volmink J.A., Gumedze F., Maartens G., et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: The investigation of the management of pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006, 6:2.
4. Imazio M., Brucato A., Mayosi B.M., Derosa F.G., Lestuzzi C., Macor A., et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown). 2010 Oct, 11(10):712-722.
5. Mutyaba A.K., Balkaran S., Cloete R., du Plessis N., Badri M., Brink J., et al. Constrictive pericarditis requiring pericardiectomy at Groote Schuur Hospital, Cape Town, South Africa: Causes and perioperative outcomes in the HIV era (1990-2012). J Thorac Cardiovasc Surg. 2014 Aug 4, pii: S0022-5223(14)01038-1.
6. Mayosi B.M., Burgess L.J., Doubell A.F. Tuberculous pericarditis. Circulation. 2005 Dec 6, 112(23):3608-3616.
7. Mayosi B.M., Ntsekhe M., Volmink J.A., Commerford P.J. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev. 2002, (4):CD000526.
8. Imazio M1, Mayosi B.M., Brucato A., Markel G., Trinchero R., Spodick D.H., et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010 Dec, 11(12):928-935.
9. Mayosi B.M., Wiysonge C.S., Ntsekhe M., et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J. 2008, 98(1):36-40.
10. Ntsekhe M., Mayosi B.M. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med. 2009 Feb, 6(2):120-127.
11. Khandaker M.H., Espinosa R.E., Nishimura R.A., et al. Symposium on cardiovascular diseases: Pericardial disease: diagnosis and management. Mayo Clin Proc 2010, 85:293-572.
12. Ntsekhe M., Matthews K., Syed F.F., Deffur A., Badri M., Commerford P.J., et al. Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion. PLoS One. 2013 Oct 14, 8(10):e77532.
13. Ntsekhe M., Wiysonge C., Volmink J.A., Commerford P.J., Mayosi B.M. Adjuvant corticosteroids for tuberculous pericarditis: Promising, but not proven. QJM. 2003, 96:593-599.
14. Mayosi B.M., et al. Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis. The New England journal of medicine (2014). N Engl J Med. 2014 Sep 18, 371(12):1121-1130.
15. Pandie S., Engel M.E., Kerbelker Z.S., Mayosi B.M. Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review. Curr Pharm Des. 2014 Sep 5, -in press.
16. Chaisson R.E., Post W.S. Immunotherapy for Tuberculous Pericarditis. N Engl J Med. 2014 Sep 1, [Epub ahead of print.
17. Uhlin M1, Andersson J., Zumla A., Maeurer M. Adjunct immunotherapies for tuberculosis. J Infect Dis. 2012 May 15, 205 Suppl 2:S325-S334. Epub 2012 Mar 29. 10.1093/infdis/jis197.
18. Zumla A., Rao M., Parida S.K., Keshavjee S., Cassell G., Wallis R., et al. Inflammation and tuberculosis: host-directed therapies. J Intern Med. 2014 Apr 10, 10.1111/joim.12256.
19. Kaufmann S.H., Lange C., Rao M., Balaji K.N., Lotze M., Schito M., et al. Progress in tuberculosis vaccine development and host-directed therapies - A state of the art review. Lancet Respiratory Med 2014, 2:301-320.
20. Young P.P., Schafer R. Cell-based therapies for cardiac disease: a cellular therapist's perspective. Transfusion. 2014 Aug 22, [Epub ahead of print]. 10.1111/trf.12826.
21. Ohnishi S., et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J mol cell cardiology 2007, 42:88-97.
22. Ishikane S., et al. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. J mol cell cardiology 2010, 49:753-761.
23. Van Linthout S., et al. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J 2011, 32:2168-2178.
24. Young P.P., Schafer R. Cell-based therapies for cardiac disease: a cellular therapist's perspective. Transfusion 2014 Aug 22, [Epub ahead of print]. 10.1111/trf.12826.
25. Skrahin A., Ahmed R.K., Ferrara G., Rane L., Poiret T., Isaikina Y., et al. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Lancet Respir Med. 2014, 2:108-122.
26. De Vlaminck K.K., Khush C., Strehl B., Kohli H., Luikart N.F., Neff J., et al. Quake, Temporal response of the human virome to immunosuppression and antiviral therapy. Cell 2013, 155:1178-1187.